ERGOTIKA TABLET / INJECTION
Ergotika 1 mg contains Co-dergocrine mesylate 1 mg / tablet
Ergotika 4.5 mg contains Co-dergocrine mesylate 4.5 mg / tablet enteric coated.
Ergotika injection contains Co-dergocrine mesylate 0.3 mg / ml
For acute cerebrovascullar disorders the drug is first administered parenterally, this is then followed by oral therapy. The dose is 0.3 mg (1 ml) administered as i.v.drip or slow i.v.injection ( in 20 ml dextrose or saline ) once or twice daily alternatively, 0.3 mg (1 ml) may be given intramuscularly or subcutaneously once to several times daily.
1 Ergotika 4.5 mg tablet preferably before breakfast or 1 to 2 mg, three times daily, unless otherwise prescribed by the physician.